Product Pipeline
|
"Resverlogix has made remarkable progress in developing molecules to enhance the transcription of ApoA-I. These molecules have excellent drug-like properties and are being rapidly moved into clinical development."
|
Due to the nature of the drug development process, Resverlogix’s product pipeline will change over time as programs move through this process. Please refer to Media Press Releases for any updates.
